Cancer gene therapy: Fringe or cutting edge?

Nature Reviews Cancer

Volumn 1, Issue 2, 2001, Pages 130-141

  McCormick, Frank ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ENZYME; ENZYME INHIBITOR; PRODRUG;

ANIMAL; APOPTOSIS; BIOTRANSFORMATION; BYSTANDER EFFECT; DEFECTIVE VIRUS; EXPERIMENTAL NEOPLASM; FEMALE; FORECASTING; GENE EXPRESSION REGULATION; GENE THERAPY; GENE VECTOR; GENETICS; HERPES VIRUS; HUMAN; IMMUNOLOGY; MASTADENOVIRUS; METABOLISM; MOUSE; MOUSE MUTANT; NEOPLASM; ONCOGENE; OVARY TUMOR; PHASE 1 CLINICAL TRIAL; PHASE 2 CLINICAL TRIAL; PHYSIOLOGY; REVIEW; TRANSGENIC MOUSE; TUMOR SUPPRESSOR GENE; VIRUS REPLICATION;

ANIMALS; APOPTOSIS; BIOTRANSFORMATION; BYSTANDER EFFECT; CLINICAL TRIALS, PHASE I; CLINICAL TRIALS, PHASE II; DEFECTIVE VIRUSES; ENZYME INHIBITORS; ENZYMES; FEMALE; FORECASTING; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE THERAPY; GENES, BRCA1; GENES, P53; GENES, TUMOR SUPPRESSOR; GENETIC VECTORS; HERPESVIRIDAE; HUMANS; MASTADENOVIRUS; MICE; MICE, KNOCKOUT; MICE, TRANSGENIC; NEOPLASMS; NEOPLASMS, EXPERIMENTAL; ONCOGENES; OVARIAN NEOPLASMS; PRODRUGS; VIRUS REPLICATION;

EID: 0035523825     PISSN: 1474175X     EISSN: None     Source Type: Journal    
DOI: 10.1038/35101008     Document Type: Article

References (22)

1. Morin, P. J., Vogelstein, B. & Kinzler, K. W. Apoptosis and APC in colorectal lumorigenesis. Proc. Natl Acad. Sci. USA 93, 7950-7954 (1996).
2. +/- mice. Proc. Natl Acad. Sci. USA 96, 3916-3921 (1999).
3. Demers, G. W. et al. A recombinant adenoviral vector expressing full-length human retinoblastoma susceptibility gene inhibits human tumor cell growth. Cancer Gene Ther. 5, 207-214 (1998).
4. PIK4A expression on cell cycle arrest are determined by endogenous p16 and Rb status in human cancer cells. Oncogens 16, 265-272 (1998).
5. PIK4A gene. Int. J. Oncol. 14, 1075-1080 (1999).
6. Tanaka, M. et al. MMAC1/PTEN inhibits cell growth and induces chemosensitivity to doxorubicin in human bladder cancer cells. Oncogene 19, 5406-5412 (2000).
7. Minaguchi, T. et al. Growth suppression of human ovarian cancer cells by adenovirus-mediated transfer of the PTEN gene. Cancer Res. 59, 6063-6067 (1999).
8. Sakurada, A. et al. Adenovirus-mediated delivery of the PTEN gene inhibits cell growth by induction of apoptosis in endometrial cancer. Int. J. Oncol. 15, 1069-1074 (1999).
9. Cheney, I. W. et al. Suppression of tumorigenicity of glioblastoma cells by adenovirus-mediated MMAC1/PTEN gene transfer. Cancer Res. 58, 2331-2334 (1998).
10. 4RF gene transfer in human mesothelioma cells. J. Natl Cancer Inst. 92, 636-641 (2000).
11. Roth, J. A. et al. Retrovirus-mediated wild-type p53 gene transfer to tumors of patients with lung cancer. Nature Med. 2, 985-991 (1996). First report of p53 delivery to cancer cells in humans. Expression of p53 and increased apoptosis in treated tumours was reported, with no evidence of toxicity. The retrovirus delivery system was not sufficiently efficient, but this paper proved the principle that delivery of p53 could kill cancer cells in vivo.
12. Seth, P. et al. A recombinant adenovirus expressing wild type p53 induces apoptosis in drug-resistant human breast cancer cells: a gene therapy approach for drug-resistant cancers. Cancer Gene Ther. 4, 383-390 (1997).
13. Holt, J. T. et al. Growth retardation and tumour inhibition by BRCA1. Nature Genet. 12, 298-302 (1996).
14. Shao, N., Chai, Y. L., Shyam, E., Reddy, P. & Rao, V. N. Induction of apoptosis by the tumor suppressor protein BRCA1. Oncogens 13, 1-7 (1996).
15. Tat, D. L. et al. A phase I trial of retroviral BRCA1sv gene therapy in ovarian cancer. Can. Cancer Res. 3, 1959-1968 (1997).
16. Vogelstein, B., Lane, D. & Levine, A. J. Surfing the p53 network. Nature 408, 307-310 (2000).
17. Kaplan, K. B. et al. A role for the adenomatous polyposis coli protein in chromosome segregation. Nature Cell Biol. 3, 429-432 (2001).
18. Fodde, R. et al. Mutations in the APC tumour suppressor gene cause chromosomal instability. Nature Cell Biol. 3, 433-438 (2001).
19. Zhang, W. W. et al. High-efficiency gene transfer and high-level expression of wild-type p53 in human lung cancer cells mediated by recombinant adenovirus. Cancer Gene Ther. 1, 5-13 (1994).
20. Nishizaki, M. et al. Recombinant adenovirus expressing wild-type p53 is antiangiogenic: a proposed mechanism for bystander effect. Clin. Cancer Res. 5, 1015-102 (1999).
21. Bouvet, M. et al. Adenovirus-mediated wild-type p53 gene transfer down-regulates vascular endothelial growth factor expression and inhibits angiogenesis in human colon cancer. Cancer Res. 58, 2288-2292 (1998).
22. Dameron, K. M., Volpert, O. V, Tainsky, M. A. & Bouck, N. The p53 tumor suppressor gene inhibits angiogenesis by stimulating the production of thrombospondin. Cold Spring Harb. Symp. Quant. Biol. 59, 483-489 (1994). First connection between p53 and angiogenesis: the discovery that p53 regulates expression of the production of thrombospondin, a protein purified by Bouck and co-workers in an early biological assay for factors that block angiogenesis.